Search Within

Lisa Bodei

Formats
  1. Meeting Abstract (69)
  2. Journal Article (62)
  3. Review (34)
  4. Book Section (18)
  5. Editorial (12)
  6. Guidelines (9)
  7. Conference Paper (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Molecular Imaging and Therapy Service (210)
  2. Radiology, Department of (210)
  3. Sloan Kettering Institute Postdocs (210)
  4. Center for Pancreatic Cancer Research (35)
  5. Department of Medicine (33)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Heiko Schoder (20)
  2. Jason Lewis (18)
  3. Diane Reidy (17)
  4. Joseph O'Donoghue (13)
  5. Simone Krebs (11)
  6. Michael Morris (10)

More People

Years
  1. 2025 (7)
  2. 2024 (15)
  3. 2023 (26)
  4. 2022 (16)
  5. 2021 (27)
  6. 2020 (31)

More Years

Publications
  1. Journal of Nuclear Medicine (36)
  2. Neuroendocrinology (32)
  3. European Journal of Nuclear Medicine and Molecular Imaging (26)
  4. Pancreas (16)
  5. Journal of Clinical Oncology (15)
  6. Radiopharmaceutical Therapy (9)

More Publications

Publishers
  1. Springer (48)
  2. Society of Nuclear Medicine (36)
  3. S. Karger AG (32)
  4. Lippincott Williams & Wilkins (22)
  5. American Society of Clinical Oncology (15)
  6. Elsevier Inc. (11)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors
    Meeting Abstract

    Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Development of PET response criteria in neuroendocrine tumors (PERCIN)
    Meeting Abstract

    Chaban, A.; Dinkel, V.; Eiber, M.; Song, Y.; Brosch-Lenz, J.; Krebs, S.; Bodei, L.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Challenges with (177)Lu-PSMA-617 radiopharmaceutical therapy in clinical practice
    Editorial

    Jadvar, H.; Iravani, A.; Bodei, L.; Calais, J.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Update in the management of gastroenteropancreatic neuroendocrine tumors
    Review

    Sedlack, A. J. H.; Varghese, D. G.; Naimian, A.; Yazdian Anari, P.; Bodei, L.; Hallet, J.; Riechelmann, R. P.; Halfdanarson, T.; Capdevilla, J.; Del Rivero, J.
    Cancer (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force
    Journal Article

    Koumarianou, A.; Filosso, P. L.; Bodei, L.; Castano, J. P.; Fernandez-Cuesta, L.; Deroose, C. M.; Foll, M.; Dromain, C.; Reed, N. S.; Caplin, M.; more...
    Journal of Neuroendocrinology (2024)

    Fulltext@MSK | Save
  • Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood
    Journal Article

    Modlin, I. M.; Kidd, M.; Drozdov, I. A.; Boegemann, M.; Bodei, L.; Kunikowska, J.; Malczewska, A.; Bernemann, C.; Koduru, S. V.; Rahbar, K.
    Prostate (2024)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): Results from a single institutional retrospective analysis
    Journal Article

    Rubino, M.; Di Stasio, G. D.; Bodei, L.; Papi, S.; Rocca, P. A.; Ferrari, M. E.; Fodor, C. I.; Bagnardi, V.; Frassoni, S.; Mei, R.; more...
    Endocrine (2024)

    Fulltext@MSK | Save
  • How can radiopharmaceutical therapies reach their full potential? Improving dose reporting and phase I clinical trial design
    Journal Article

    Kiess, A. P.; O'Donoghue, J.; Uribe, C.; Bodei, L.; Hobbs, R. F.; Hesterman, J.; Kesner, A. L.; Sgouros, G.; on behalf of the RPT-TEC group
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Radiopharmaceuticals for cancer diagnosis and therapy: New targets, new therapies - Alpha-emitters, novel targets
    Review

    Taunk, N. K.; Escorcia, F. E.; Lewis, J. S.; Bodei, L.
    The Cancer Journal (2024)

    Fulltext@MSK | Save